Director, Precision Medicine
GSK
Dr. Vivaswath Ayyar is Director, Clinical Pharmacology Modeling & Simulation, within Precision Medicine at GSK. As an experienced R&D scientist and quantitative medicine leader, Dr. Ayyar is dedicated to advancing drug development through innovative, data-driven, and model-informed strategies that enhance decision-making and deliver impactful outcomes for both projects and patients. His current efforts focus on developing and applying mechanism-based PK/PD and modality-centric quantitative systems pharmacology (QSP) models to drive GSK's hepatology and infectious disease portfolios. This includes the model-informed development of novel biologics and oligonucleotide therapeutics, particularly small interfering RNAs (siRNAs).
Dr. Ayyar received a Bachelor of Science in Biological Sciences from the University at Buffalo in 2014, followed by a PhD in Pharmaceutical Sciences in 2019, where he worked under the mentorship of Dr. William Jusko. Prior to joining GSK, he spent six years at Johnson & Johnson, where his team established foundational PK-PD concepts and mechanistic models for siRNA therapeutics, which are now widely used in academia, industry, and regulatory settings to advance oligonucleotide R&D.
In addition to his role at GSK, Dr. Ayyar serves as an Adjunct Assistant Professor of Pharmaceutical Sciences at the University at Buffalo. He has authored over 25 peer-reviewed publications, reviews, and patents.
Disclosure information not submitted.
Wednesday, May 7, 2025
2:45 PM - 3:00 PM ET